Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC. Hammond ME, et al. Among authors: mcshane l. Arch Pathol Lab Med. 2010 Jun;134(6):907-22. doi: 10.5858/134.6.907. Arch Pathol Lab Med. 2010. PMID: 20524868 Free PMC article.
Statistical issues in tumor marker studies.
Pajak TF, Clark GM, Sargent DJ, McShane LM, Hammond ME. Pajak TF, et al. Among authors: mcshane lm. Arch Pathol Lab Med. 2000 Jul;124(7):1011-5. doi: 10.5858/2000-124-1011-SIITMS. Arch Pathol Lab Med. 2000. PMID: 10888777 Free article.
REporting recommendations for tumour MARKer prognostic studies (REMARK).
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. McShane LM, et al. Eur J Cancer. 2005 Aug;41(12):1690-6. doi: 10.1016/j.ejca.2005.03.032. Eur J Cancer. 2005. PMID: 16043346
Reporting recommendations for tumor marker prognostic studies (REMARK).
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. McShane LM, et al. J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4. doi: 10.1093/jnci/dji237. J Natl Cancer Inst. 2005. PMID: 16106022
Reporting recommendations for tumor marker prognostic studies.
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. McShane LM, et al. J Clin Oncol. 2005 Dec 20;23(36):9067-72. doi: 10.1200/JCO.2004.01.0454. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172462 No abstract available.
REporting recommendations for tumor MARKer prognostic studies (REMARK).
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics. McShane LM, et al. Breast Cancer Res Treat. 2006 Nov;100(2):229-35. doi: 10.1007/s10549-006-9242-8. Epub 2006 Aug 24. Breast Cancer Res Treat. 2006. PMID: 16932852
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. Wolff AC, et al. Among authors: mcshane lm. J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159189
215 results